[Cardiovascular therapy for sepsis: when, how and how much?]

Area of Science:

• Emergency Medicine
• Critical Care Medicine
• Cardiovascular Physiology

Background:

• Hemodynamic instability significantly impacts sepsis outcomes, increasing organ complications and mortality.
• Maintaining adequate mean arterial pressure (MAP) is vital, with guidelines recommending MAP not fall below 65 mm Hg.
• Sepsis management guidelines emphasize fluid resuscitation and vasopressors for cardiovascular support.

Purpose of the Study:

• To critically discuss the optimal strategies for managing hemodynamic instability in sepsis.
• To provide evidence-based recommendations on the 'what, when, and how much' of circulatory therapy for septic patients.
• To enhance clinical decision-making in emergency and intensive care settings for sepsis management.

Main Methods:

• Review of current guidelines and literature on sepsis management.
• Critical analysis of fluid therapy (crystalloid balanced fluids) and pharmacologic agents (catecholamines).
• Discussion of timing, volume, and type of interventions for hemodynamic support.

Main Results:

• Balanced crystalloid fluids and catecholamines are foundational treatments for septic cardiovascular instability.
• The article emphasizes the importance of individualized therapy based on patient response.
• Key considerations for effective resuscitation include early and appropriate intervention.

Conclusions:

• Optimizing circulation therapy is essential for improving outcomes in sepsis and septic shock.
• Adherence to MAP targets and judicious use of fluids and vasopressors are critical.
• Further research may refine best practices in hemodynamic management for sepsis.